Cargando…
Personalized Risk-Based Screening Design for Comparative Two-Arm Group Sequential Clinical Trials
Personalized medicine has been emerging to take into account individual variability in genes and environment. In the era of personalized medicine, it is critical to incorporate the patients’ characteristics and improve the clinical benefit for patients. The patients’ characteristics are incorporated...
Autor principal: | Park, Yeonhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953575/ https://www.ncbi.nlm.nih.gov/pubmed/35330448 http://dx.doi.org/10.3390/jpm12030448 |
Ejemplares similares
-
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
por: Park, Yeonhee
Publicado: (2021) -
Sample size determination and evaluation for two-stage adaptive designs of single arm clinical trials based on median event time test
por: Park, Yeonhee, et al.
Publicado: (2023) -
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021) -
Multi‐arm group sequential designs with a simultaneous stopping rule
por: Urach, S., et al.
Publicado: (2016) -
Group sequential and confirmatory adaptive designs in clinical trials
por: Wassmer, Gernot, et al.
Publicado: (2016)